STOCK TITAN

Senestech Stock Price, News & Analysis

SNES NASDAQ

Company Description

SenesTech, Inc. (NASDAQ: SNES) is a biotechnology company focused on fertility control for managing animal pest populations. According to the company’s public statements, SenesTech is committed to creating healthier environments by humanely managing rodent populations through contraceptive technologies rather than traditional poisons. Its products are designed to integrate into integrated pest management (IPM) programs and to support cleaner cities, efficient businesses, and healthier communities with solutions that are humane, effective, and sustainable.

SenesTech describes itself as a pioneer in rodent birth control. The company developed ContraPest®, which it states is the first and only U.S. Environmental Protection Agency (EPA)–registered contraceptive for male and female rats. In addition, SenesTech has developed Evolve Rat and Evolve Mouse Birth Control products, which are characterized in company materials as EPA-designated minimum-risk contraceptives for rodents. These offerings are positioned as long-term, fertility-based tools for rodent population control.

The company reports that its Evolve-branded products are used in agricultural, commercial, municipal, and consumer settings. Press releases note deployments in urban programs, including municipal pilots in locations such as New York City, Chicago, Boston, Baltimore, Los Angeles County, San Francisco, and other cities, as well as community pilots like the Town of Swampscott’s firehouse and school initiative. SenesTech also highlights use by pest management professionals and availability through retail and e-commerce channels.

SenesTech’s business model, as reflected in its disclosures, centers on the development, manufacturing, and commercialization of fertility control baits for rodents. The company emphasizes that its products are intended to fit seamlessly into existing pest management programs and to reduce reliance on traditional rodenticides. In multiple communications, SenesTech describes its approach as addressing the root cause of infestations by reducing reproduction rather than increasing the death rate.

Within its product portfolio, the company identifies Evolve Rat Birth Control as a soft bait that targets rat reproduction and is described as non-lethal and non-poisonous. Company news indicates that Evolve Rat is widely deployed in agricultural, commercial, and municipal environments and is also marketed to homeowners and do-it-yourself consumers. Evolve Mouse is presented as a related fertility control product for mice, and ContraPest is positioned as an EPA-registered contraceptive for rats.

SenesTech’s public updates describe a multi-channel distribution strategy. The company reports revenue contributions from e-commerce platforms, municipal programs, brick-and-mortar retail partners, and pest management professionals. E-commerce channels mentioned in company releases include Amazon and several major retail websites. Retail distribution is described through partners such as Ace Hardware and wholesalers that serve thousands of retail locations. Municipal deployments and pilot programs are cited as another channel that can also support awareness and adoption across retail and e-commerce.

In addition to domestic activities, SenesTech references international partnerships and regulatory efforts. Company news highlights regulatory approvals and distribution arrangements in various countries, including an international distributor relationship with the Belize Raptor Center for Evolve Rat Birth Control, following approval by the Pesticides Control Board of Belize. SenesTech also notes regulatory processes and distribution agreements in other regions in its financial and operational updates.

SenesTech’s filings and press releases also describe its capital markets and financing activities. The company has entered into at-the-market (ATM) offering arrangements with a sales agent, registered additional shares under that program, and completed warrant inducement transactions that generated gross proceeds for working capital and general corporate purposes. These activities are documented in its Form 8-K filings and related prospectus supplements.

The company’s common stock is listed on The Nasdaq Stock Market LLC under the symbol SNES, as disclosed in multiple Form 8-K filings. SenesTech identifies its headquarters city as Surprise, Arizona in SEC filings, reflecting its corporate location. The company’s sector and industry classification align with manufacturing and pesticide and other agricultural chemical manufacturing, consistent with its focus on rodent fertility control products.

SenesTech’s public mission statements emphasize humane, proactive, and sustainable pest management. Across its communications, the company states that it aims to improve the health of the world and to protect people, property, and the planet through fertility-based rodent control. Its messaging underscores the goal of reducing secondary wildlife poisonings and environmental contamination associated with traditional rodenticides, while providing tools that can be incorporated into existing pest management practices.

Stock Performance

$—
0.00%
0.00
Last updated:
-9.5%
Performance 1 year

Senestech (SNES) stock last traded at $1.62. Over the past 12 months, the stock has lost 9.5%. At a market capitalization of $8.6M, SNES is classified as a micro-cap stock with approximately 5.3M shares outstanding.

Latest News

Senestech has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include earnings, earnings date, conferences, clinical trial. View all SNES news →

SEC Filings

Senestech has filed 5 recent SEC filings, including 2 Form 4, 1 Form SCHEDULE 13G/A, 1 Form 10-K, 1 Form 8-K. The most recent filing was submitted on March 18, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SNES SEC filings →

Insider Radar

Net Buyers
90-Day Summary
344,988
Shares Bought
0
Shares Sold
13
Transactions
Most Recent Transaction
GLENBROOK CAPITAL MANAGEMENT (Insider) bought 19,725 shares @ $1.79 on March 17, 2026

Insider buying activity at Senestech over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.

Based on SEC Form 4 filings over the last 90 days.

Financial Highlights

Senestech generated $2.2M in revenue over the trailing twelve months, retaining a 62.5% gross margin, operating income reached -$6.5M (-292.9% operating margin), and net income was -$6.4M, reflecting a -287.4% net profit margin. Diluted earnings per share stood at $-1.95. The company generated -$5.8M in operating cash flow. With a current ratio of 12.61, the balance sheet reflects a strong liquidity position.

$2.2M
Revenue (TTM)
-$6.4M
Net Income (TTM)
-$5.8M
Operating Cash Flow

Upcoming Events

JUN
30
June 30, 2026 Corporate

CEO retirement deadline

CEO Joel Fruendt to depart by this date unless a successor is named; interim chair appointed

Senestech has 1 upcoming scheduled event. The next event, "CEO retirement deadline", is scheduled for June 30, 2026 (in 86 days). Investors can track these dates to stay informed about potential catalysts that may affect the SNES stock price.

Short Interest History

Last 12 Months

Short interest in Senestech (SNES) currently stands at 27.8 thousand shares, down 43.7% from the previous reporting period, representing 0.6% of the float. Over the past 12 months, short interest has decreased by 75.6%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for Senestech (SNES) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 63% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 14.6 days.

SNES Company Profile & Sector Positioning

Senestech (SNES) operates in the Specialty Chemicals industry within the broader Agricultural Chemicals sector and is listed on the NASDAQ.

Investors comparing SNES often look at related companies in the same sector, including Cn Energy Group Inc (CNEY), Bolt Projects Holdings Inc (BSLK), Bionexus Gene La (BGLC), Bon Natural Life Ltd (BON), and Northern Techn (NTIC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SNES's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Senestech (SNES)?

The current stock price of Senestech (SNES) is $1.62 as of April 3, 2026.

What is the market cap of Senestech (SNES)?

The market cap of Senestech (SNES) is approximately 8.6M. Learn more about what market capitalization means .

What is the revenue (TTM) of Senestech (SNES) stock?

The trailing twelve months (TTM) revenue of Senestech (SNES) is $2.2M.

What is the net income of Senestech (SNES)?

The trailing twelve months (TTM) net income of Senestech (SNES) is -$6.4M.

What is the earnings per share (EPS) of Senestech (SNES)?

The diluted earnings per share (EPS) of Senestech (SNES) is $-1.95 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Senestech (SNES)?

The operating cash flow of Senestech (SNES) is -$5.8M. Learn about cash flow.

What is the profit margin of Senestech (SNES)?

The net profit margin of Senestech (SNES) is -287.4%. Learn about profit margins.

What is the operating margin of Senestech (SNES)?

The operating profit margin of Senestech (SNES) is -292.9%. Learn about operating margins.

What is the gross margin of Senestech (SNES)?

The gross profit margin of Senestech (SNES) is 62.5%. Learn about gross margins.

What is the current ratio of Senestech (SNES)?

The current ratio of Senestech (SNES) is 12.61, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Senestech (SNES)?

The gross profit of Senestech (SNES) is $1.4M on a trailing twelve months (TTM) basis.

What is the operating income of Senestech (SNES)?

The operating income of Senestech (SNES) is -$6.5M. Learn about operating income.

What does SenesTech, Inc. do?

SenesTech, Inc. focuses on managing animal pest populations, particularly rodents, through fertility control. The company develops and commercializes contraceptive bait products that are designed to integrate into integrated pest management programs and reduce reliance on traditional rodenticides.

What products does SenesTech offer for rodent control?

SenesTech identifies three main rodent fertility control products in its public materials: ContraPest®, described as the first and only U.S. EPA-registered contraceptive for male and female rats, and Evolve Rat and Evolve Mouse Birth Control, which it characterizes as EPA-designated minimum-risk contraceptives for rodents.

How is Evolve Rat Birth Control described by SenesTech?

According to company press releases, Evolve Rat Birth Control is a soft bait that targets rat reproduction. It is described as a non-lethal, non-poisonous product that reduces rat populations humanely and sustainably by addressing reproduction rather than relying solely on lethal control methods.

In what settings are SenesTech’s products used?

SenesTech states that its Evolve Rat product is deployed in agricultural, commercial, and municipal settings and is also marketed to homeowners and do-it-yourself consumers. Company news also references municipal pilot programs in various U.S. cities and community sites such as firehouses and schools.

How does SenesTech position its approach to pest management?

The company positions its approach as addressing the root cause of rodent infestations by decreasing the birth rate rather than increasing the death rate. It emphasizes humane, proactive, and sustainable fertility control that can fit into existing integrated pest management programs and reduce dependence on traditional poisons.

Where is SenesTech’s stock listed and what is its ticker symbol?

SenesTech’s common stock is listed on The Nasdaq Stock Market LLC under the ticker symbol SNES, as disclosed in multiple Form 8-K filings.

Does SenesTech operate internationally?

Company news indicates that SenesTech works with international partners and regulators. For example, it has reported that the Belize Raptor Center became an international distributor of Evolve Rat Birth Control after approval by the Pesticides Control Board of Belize, and it has referenced regulatory processes and distribution agreements in other countries.

What is SenesTech’s stated mission?

SenesTech’s mission statements in its press releases describe a commitment to improving the health of the world by humanely managing animal pest populations through fertility control. The company says it strives for cleaner cities, more efficient businesses, and healthier communities with products that are humane, effective, and sustainable.

How does SenesTech raise capital for its operations?

According to its Form 8-K filings, SenesTech has used at-the-market equity offerings and warrant inducement transactions to raise capital. These transactions involve selling common stock under an ATM agreement and entering into agreements with warrant holders to exercise existing warrants in exchange for new warrants, with proceeds intended for working capital and general corporate purposes.

What role do pest management professionals play in SenesTech’s business?

SenesTech reports that pest management professionals incorporate Evolve products into their service offerings. Company financial updates state that this channel contributes to revenue and that professionals use the fertility control attributes across a range of customer applications.